Vpr was shown to suppress the activity of peroxisome proliferator-activated receptor-gamma (PPARγ) [37], which could lead to vascular remodelling and endothelial dysfunction through enhanced vascular oxidative stress and inflammation [38]. The gene discussed is PPARG; the disease is endothelial dysfunction.